tirzepatide weight loss timeline percentages The best weight-loss injections in 2026 | Mounjaro | Wegovy Retatrutide vs Tirzepatide- Which Weight

Citing recent anecdotal reports purporting an association of delayed gastric emptying with use of GLP-1 receptor agonists and increased risk of regurgitation and pulmonary aspiration during general anesthesia and deep sedation, the ASA task force set forth to provide the community with guidance on scheduled elective procedures for patients who are using GLP-1 receptor agonists

Current treatments, other than insulin supplementation, are sometimes not sufficient to achieve control and may cause undesirable side effects, such as weight gain and hypoglycemia

fever, sore throat, superficial mouth ulcers, flu-like symptoms, severe exhaustion, nose and skin bleeding Worsening of asthma, bronchospasm, dyspnoea Stomach or intestinal ulcers, sometimes with bleeding and perforation, inflammation of the lining of the mouth with ulcers, inflammation of the stomach Hepatitis, jaundice, abnormal liver function Sleeplessness, agitation, irritability Insomnia, anxiety Visual disturbances Sensitivity to light Allergic reactions, e.g

Hepatol Res 2011;41:670-674